Nanomaterials, 2024 · DOI: https://doi.org/10.3390/nano14050389 · Published: February 20, 2024
This study introduces a novel nanoparticle, PMC NPs, designed to combat oxidative stress and inflammation in neural diseases. It combines the ROS scavenging ability of a nanozyme with the anti-inflammatory properties of curcumin. The PMC NPs exhibit excellent dispersibility, cytocompatibility, and enzyme-mimetic activities, specifically SOD-like and CAT-like activities, which are crucial for neutralizing harmful reactive oxygen species (ROS). The curcumin component further enhances the anti-inflammatory effect by suppressing the expression of inflammatory cytokines. In vitro experiments demonstrated that PMC NPs effectively scavenged ROS in microglia and neuronal cells, mitigated DNA and lipid oxidation, and increased cell viability under oxidative stress, suggesting their potential as therapeutic agents for neural diseases.
PMC NPs could be developed into a therapeutic agent for neurological disorders characterized by oxidative stress and inflammation, such as spinal cord injury, traumatic brain injury, Alzheimer’s disease, and Parkinson’s disease.
The nanoplatform can be further explored for targeted drug delivery to specific areas in the nervous system, enhancing treatment efficacy and reducing side effects.
The study provides insights into the design of multifunctional nanomaterials that combine antioxidant and anti-inflammatory properties, paving the way for advanced nanomedicine applications.